The pharmaceutical company Farmak has supplemented its portfolio with a new brand – hepatic medicine Hep-Art. The drug is available as a lyophilisate solution for injection.
The new product of Farmak – Hep-Art contains an active substance ademetionine.
Ademetionine deficiency plays a key role in the hepatopathy. Reduced ademetionine level deteriorates the liver condition leading to inflammation and further to irreversible structural and degenerative changes in the liver.* Hep-Art eliminates deficiency of the endogenous ademetionine and stimulates its production in the body.
According to the instructions, it is indicated to treat:
intrahepatic cholestasis in adults, including patients with chronic hepatitis of various etiologies and cirrhosis; intrahepatic cholestasis of pregnancy; depressive syndromes.
Olga Vereshchaka, Farmak Product Manager, "Hep-Art helps to restore the liver. Hep-Art acts as an antioxidant; it regenerates hepatic cells, and improves bile production and outflow. The triple action determines 7 effects of Hep-Art: choleretic, cholekinetic, antioxidant, detoxification, regeneration, neuroprotective,** antidepressant. Thus, we are able to treat patients with the intrahepatic cholestasis syndrome, getting improvement in their condition."
The drug is sold by prescription only.
Farmak searches for engaging startups in the innovative medical technology market in cooperation with Sector X. “Why are we here? To find new business development points in P4 (predictive, preventive, personalized and participatory) medicine. Admittedly, the corporate sector may effectively operate a customized business model, but it is cumbersome enough to ...
The purpose of the Memorandum is to consolidate the efforts of business and scientific institutions to support talented students and to increase the scientific potential of the country. The project implementation will open the new opportunities for talented youth, who will be awarded at the all-Ukrainian contests where they will present their research works....
We start searching for engaging startups in the innovative medical technology market in cooperation with Sector X. What will a startup gain from participating in the acceleration hub? The opportunity to launch a pilot with the leader of the Ukrainian pharmaceutical market Farmak The expertise from Farmak representatives The step-by-step acceleration programm...